tin sponges (gelfoam), coils, thrombin, polyvinyl alcohol particles, absolute alcohol, and N-butyl cyanoacrylate have been
INTRODUCTION
Hepatocellular carcinoma (HCC) is the fifth most common neoplasm in the world, and the third most common cause of cancer-related death (1) . According to the Barcelona Clinic Liver Cancer staging classification and treatment schedule, surgical resection is considered the first treatment option for patients with early-stage HCC (2) . However, liver resection may be contraindicated if the future liver remnant (FLR) volume is not sufficient to avoid post-hepatectomy liver failure. Patients treated with portal vein embolization (PVE) before a major liver resec-tion for HCC show fewer postoperative complications and better cumulative survival rates than those who have not received PVE (3, 4) . The minimal FLR volume required following liver resection is > 25% in patients with normal livers and > 40% in those with chronic liver disease (5) , and liver regeneration is slower in the non-embolized lobe paired with an injured liver than in the normal liver (6, 7) . Therefore, more efficient PVE is necessary for patients with chronic liver disease. Table 1 . HCC was confirmed histopathologically in 37 tumors from 32 patients who underwent hepatic resection, and six tumors of five patients who did not undergo hepatic resection were considered to be HCC based on the imaging and laboratory findings according to the American Association for the Study of Liver Disease guidelines. The diagnosis of HCC was based on biopsy or imaging findings that showed intense arterial uptake followed by washout of contrast in the venous-delayed phase on CT or MRI (14) .
Evaluation of Effectiveness of PVE

Measurement of Liver Volume
It has been reported that CT volumetry can accurately assess liver volumes (5) . In all patients, CT scanning was performed before and after PVE. All CT examinations before and after PVE were performed using one of four helical scanners (LightSpeed QX/1, LightSpeed16, or LightSpeed Ultra; GE Medical Systems, Milwaukee, WI, USA or Aquilion; Toshiba Medical Systems used for PVE (8) . A few animal studies showed that PVE using permanent embolic substances is more effective than PVE using temporary substances (9, 10) . Although PVE has been performed using gelfoam and coils (11) (12) (13) , few reports exist regarding the comparison of the effectiveness of gelfoam alone and a gelfoamcoil combination in PVE. Therefore, the purpose of this study was to compare the effectiveness of PVE performed using gelfoam alone and a gelfoam-coil combination in patients with HCC.
MATERIALS AND METHODS
Patients
This study was performed with the approval of our Institu- 
RESULTS
Primary technical success of PVE was achieved in all patients.
There were no complications related to the procedure. Five patients (13.5%, 5/37) did not undergo hepatic resection after PVE for the following reasons: extrahepatic metastasis (n = 2), intrahepatic metastasis (n = 2), and aggravation of hyperbilirubinemia caused by bile duct invasion (n = 1). Therefore, 32 patients subsequently underwent hepatectomy (right hepatectomy: 25, extended right hepatectomy: 7) after PVE.
The median hospital stay after PVE was 1.6 ± 0.9 days (range:
1-5 days) and there was no significant difference between the two groups (p = 0.94). Pre-and post-PVE laboratory tests for liver function were similar in both groups ( Table 2 ).
There were no operative mortalities or major complications in either the GG or GCG after PVE and surgery. There were several minor postoperative complications, including wound problems such as seroma (n = 4), pleural effusion (n = 1), and peritoneal fluid collection with fever (n = 1). These patients with minor complications were discharged within 3 weeks.
Liver Volume Changes
There was no significant difference in TLV, FLR before PVE, and % FLR between the GG and GCG ( Table 3 ).
The FLR volume increased from 365. 
Statistical Analysis
All data are expressed as mean ± standard deviation. The
Mann-Whitney U test was used to analyze the differences between two groups in TLV, RLV, % FLR, and the % increase of FLR volume after PVE, as well as the tumor size before and after PVE. Comparison of the recanalization rate between two groups was performed using the chi-square test. A p value < 0.05 was considered statistically significant. Statistical analysis was performed using commercially available statistics software (Statisti- 1-70.9%) in GG and 36.7 ± 18.5% (range 8.4-83.2%) in GCG, respectively (p = 0.02) ( Table 3) .
Portal Vein Recanalization
Portal vein recanalization after PVE was observed in 15/17 after PVE in GG and from 358.4 ± 121.6 cm 3 (range 174.3-673.5 cm 3 ) to 480.2 ± 140.3 cm 3 (range 220.9-730.4 cm 3 ) after PVE in GCG. The increased FLR volume was significantly different between the two groups (p = 0.02). The mean % increase of FLR volume induced by PVE was 23.7 ± 23.7% (range Table 2 combinations have been used clinically as embolic materials for PVE in several previous studies (11-13, 19, 20) , but few studies have compared the efficacy between permanent and temporary embolic materials. Some interventional radiologists in our institution performed PVE with gelfoam alone because of a few advantages, including safety, low price, easy handling, and minimal inflammatory reaction. In addition, they thought that even if migration of gelfoam into portal branches of the contralateral lobe occurred, there would be minimal or no effect on the contralateral lobe because gelfoam is an absorbable biomaterial.
. Comparison of Liver Function Test between Gelfoam and Gelfoam-Coil Groups
However, initial studies with gelfoam reported frequent recanalization (16, 21) and less hypertrophy compared with permanent (88.2%) patients in GG and in 8/20 (40%) patients in GCG, respectively (p = 0.003). Complete recanalization of the portal vein was observed in 14/15 (93.3%) patients in GG and 3/8 (37.5%) patients in GCG. The mean % increase of FLR volume was 29.9 ± 26.12% in the recanalization group and 37 ± 15.6%
in the non-recanalization group (p = 0.219).
Changes in Tumor Size
The mean tumor size increased from 4.5 ± 2.9 cm before PVE to 5.0 ± 3.5 cm after PVE in the GG and from 4.3 ± 2.2 cm before PVE to 4.7 ± 2.5 cm after PVE in the GCG. There was no significant difference in tumor size changes between the groups before and after PVE ( Table 4 ). The mean tumor size increased from 4.2 ± 2.5 cm before PVE to 4.6 ± 2.9 cm in the recanalization group and from 4.9 ± 2.7 cm before PVE to 5.3 ± 3.2 cm in the non-recanalization group (p = 0.816).
DISCUSSION
Since its first clinical application in patients with hilar bile duct cancer to induce compensatory FLR hypertrophy (16) , PVE has become a safe and effective procedure for preventing post-resection liver failure due to an insufficient liver remnant (8) . Although the normal liver is known to tolerate removal of up to 60% of its volume (5), major hepatectomy in patients with chronic liver disease such as chronic hepatitis or liver cirrhosis is related to the risk of hepatic failure due to impaired liver regeneration (17) . In addition, the rate of postoperative complications is significantly reduced after preoperative PVE in patients with showed that the segmental volume was overestimated by the classic Couinaud' s method by up to 24% and underestimated by 13%.
In conclusion, this study demonstrates that PVE using a gelfoam-coil combination before major hepatectomy for HCC is more effective than PVE using gelfoam alone for induction of compensatory hypertrophy and there is no significant tumor growth rate after PVE between two groups. embolic materials (22) . Therefore, the other interventional radiologists in our hospital added coils as embolic materials to prevent recanalization by occlusion of proximal portal blood flow.
In addition, an experimental study reported that proximal and complete revascularization occurred 6-8 and 12-16 days after PVE using gelfoam (23 Our study showed that PVE using a gelfoam-coil combination in patients with chronic liver disease is more likely to induce greater compensatory hypertrophy of the non-embolized portion of the liver than PVE using gelfoam alone. Furthermore, PVE using a gelfoam-coil combination showed no significant differences in postprocedural complications. Therefore, we believe that PVE should be performed using permanent embolic materials in patients with liver damage.
Since the first description of the potential of intrahepatic tumor enlargement after PVE (24) , accumulating evidence has shown that PVE stimulates tumor growth in both embolized and non-embolized liver segments (13, 25) . Hayashi et al. (26) reported that the median tumor growth rate of primary liver cancer in the embolized lobe after PVE was approximately two times greater than that before PVE. Three possible mechanisms have been proposed: changes in cytokine and growth factor secretion, alteration in hepatic blood flow, and enhanced cellular host response that promotes local tumor growth (27) . To the best of our knowledge, few studies have compared the tumor growth rate according to the embolic materials used. There was no significant difference in tumor growth rate between the two groups in this study.
The limitations of this study include the following. First, it is a retrospective study. Second, there may be a gap between the estimated FLR volume using CT volumetry according to Couinaud' s classification and the actual FLR volume. Fischer et al. (28) 
